Clinical Trial Update: A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine as adjuvant therapy after surgical resection for cholangiocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Cholangiocarcinoma | Phase 2 | Status: COMPLETED